1. Home
  2. BYND vs CMPX Comparison

BYND vs CMPX Comparison

Compare BYND & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BYND
  • CMPX
  • Stock Information
  • Founded
  • BYND 2009
  • CMPX 2014
  • Country
  • BYND United States
  • CMPX United States
  • Employees
  • BYND N/A
  • CMPX N/A
  • Industry
  • BYND Packaged Foods
  • CMPX Biotechnology: Pharmaceutical Preparations
  • Sector
  • BYND Consumer Staples
  • CMPX Health Care
  • Exchange
  • BYND Nasdaq
  • CMPX Nasdaq
  • Market Cap
  • BYND 258.5M
  • CMPX 291.8M
  • IPO Year
  • BYND 2019
  • CMPX N/A
  • Fundamental
  • Price
  • BYND $2.58
  • CMPX $2.97
  • Analyst Decision
  • BYND Sell
  • CMPX Strong Buy
  • Analyst Count
  • BYND 3
  • CMPX 8
  • Target Price
  • BYND $3.67
  • CMPX $13.50
  • AVG Volume (30 Days)
  • BYND 4.1M
  • CMPX 1.3M
  • Earning Date
  • BYND 08-06-2025
  • CMPX 08-11-2025
  • Dividend Yield
  • BYND N/A
  • CMPX N/A
  • EPS Growth
  • BYND N/A
  • CMPX N/A
  • EPS
  • BYND N/A
  • CMPX N/A
  • Revenue
  • BYND $301,353,000.00
  • CMPX N/A
  • Revenue This Year
  • BYND N/A
  • CMPX N/A
  • Revenue Next Year
  • BYND $3.36
  • CMPX N/A
  • P/E Ratio
  • BYND N/A
  • CMPX N/A
  • Revenue Growth
  • BYND N/A
  • CMPX N/A
  • 52 Week Low
  • BYND $2.23
  • CMPX $1.15
  • 52 Week High
  • BYND $7.60
  • CMPX $4.08
  • Technical
  • Relative Strength Index (RSI)
  • BYND 33.97
  • CMPX 50.84
  • Support Level
  • BYND $2.61
  • CMPX $2.66
  • Resistance Level
  • BYND $2.89
  • CMPX $3.47
  • Average True Range (ATR)
  • BYND 0.16
  • CMPX 0.25
  • MACD
  • BYND -0.05
  • CMPX -0.02
  • Stochastic Oscillator
  • BYND 1.14
  • CMPX 38.27

About BYND Beyond Meat Inc.

Beyond Meat Inc is a provider of plant-based meat company offering a portfolio of revolutionary plant-based meats. It builds meat directly from plants, an innovation that enables consumers to experience the taste, texture and other sensory attributes of popular animal-based meat products while enjoying the nutritional and environmental benefits of eating plant-based meat product It has products such as burgers, sausage, ground beef, jerky, meatballs and chicken. The company generates revenue from sales of its products to the customers across mainstream grocery, mass merchandiser, club store, convenience store and natural retailer channels and various food-away-from-home channels, including restaurants, foodservice outlets and schools, mainly in the United States.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.

Share on Social Networks: